These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12121565)

  • 21. [Infliximab].
    Herrera E; Habicheyn S
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab in psoriasis and psoriatic arthritis.
    Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximab.
    Mössner R; Reich K
    Curr Probl Dermatol; 2009; 38():107-136. PubMed ID: 19710553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab for the treatment of severe pustular psoriasis.
    Elewski BE
    J Am Acad Dermatol; 2002 Nov; 47(5):796-7. PubMed ID: 12399781
    [No Abstract]   [Full Text] [Related]  

  • 25. Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a review.
    Kamili QU; Miner A; Hapa A; Menter A
    J Drugs Dermatol; 2011 May; 10(5):539-44. PubMed ID: 21533302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab for the treatment of psoriasis.
    Kleyn CE; Griffiths CE
    Expert Opin Biol Ther; 2006 Aug; 6(8):797-805. PubMed ID: 16856801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infliximab in dermatological treatment: beyond psoriasis.
    Rigopoulos D; Korfitis C; Gregoriou S; Katsambas AD
    Expert Opin Biol Ther; 2008 Jan; 8(1):123-33. PubMed ID: 18081542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term management of generalized pustular psoriasis with infliximab: case series.
    Routhouska SB; Sheth PB; Korman NJ
    J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
    Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
    Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions.
    Oh CJ; Das KM; Gottlieb AB
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):829-30. PubMed ID: 10775863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infliximab for psoriasis.
    Gottlieb AB
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S112-7. PubMed ID: 12894134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab.
    Schopf RE; Aust H; Knop J
    J Am Acad Dermatol; 2002 Jun; 46(6):886-91. PubMed ID: 12063486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis.
    Gottlieb AB; Chaudhari U; Mulcahy LD; Li S; Dooley LT; Baker DG
    J Am Acad Dermatol; 2003 Jun; 48(6):829-35. PubMed ID: 12789171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
    Wozel G; Vitéz L; Meurer M
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):133-6. PubMed ID: 18853077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.
    Torii H; Nakagawa H;
    J Dermatol Sci; 2010 Jul; 59(1):40-9. PubMed ID: 20547039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different response rates between palmoplantar involvement and diffuse plaque psoriasis in patients treated with infliximab.
    Brunasso AM; Puntoni M; Delfino C; Massone C
    Eur J Dermatol; 2012; 22(1):133-5. PubMed ID: 22134100
    [No Abstract]   [Full Text] [Related]  

  • 37. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
    Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
    Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-TNF agents and nail psoriasis: a single-center, retrospective, comparative study.
    Kyriakou A; Patsatsi A; Sotiriadis D
    J Dermatolog Treat; 2013 Jun; 24(3):162-8. PubMed ID: 22136334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of pustular psoriasis with infliximab.
    Weishaupt C; Metze D; Luger TA; Ständer S
    J Dtsch Dermatol Ges; 2007 May; 5(5):397-9. PubMed ID: 17451384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis and its treatment with infliximab-mediated tumor necrosis factor alpha blockade.
    Winterfield L; Menter A
    Dermatol Clin; 2004 Oct; 22(4):437-47, ix. PubMed ID: 15450339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.